Last updated on February 2019

Study of Urelumab in Subjects With Advanced and/or Metastatic Malignant Tumors

Brief description of study

The purpose of this study is to assess the safety and tolerability of BMS-663513 in subjects with advanced and/or metastatic malignant tumors.

Clinical Study Identifier: NCT02534506

Contact Investigators or Research Sites near you

Start Over

Site 0001

Local Institution
Kobe-shi, Japan

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.